Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $13.84 USD
Change Today +0.70 / 5.33%
Volume 37.8K
TBRA On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 06/1/15 All times are local (Market data is delayed by at least 15 minutes).

tobira therapeutics inc (TBRA) Snapshot

Open
$12.98
Previous Close
$13.14
Day High
$13.90
Day Low
$12.90
52 Week High
06/27/14 - $66.24
52 Week Low
11/26/14 - $7.20
Market Cap
241.1M
Average Volume 10 Days
42.7K
EPS TTM
$-14.37
Shares Outstanding
17.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TOBIRA THERAPEUTICS INC (TBRA)

Related News

No related news articles were found.

tobira therapeutics inc (TBRA) Related Businessweek News

No Related Businessweek News Found

tobira therapeutics inc (TBRA) Details

Tobira Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapeutics to treat liver diseases, human immunodeficiency virus (HIV)-1, kidney fibrosis, and inflammation. It offers cenicriviroc, an immumodulator and dual inhibitor of CCR2 and CCR5 for the treatment of non-alcoholic steatohepatitis (NASH), HIV, and others. The company was founded in 2006 and is based in South San Francisco, California.

13 Employees
Last Reported Date: 03/6/15
Founded in 2006

tobira therapeutics inc (TBRA) Top Compensated Officers

Chief Medical Officer
Total Annual Compensation: $335.0K
Compensation as of Fiscal Year 2013.

tobira therapeutics inc (TBRA) Key Developments

Tobira Therapeutics, Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-13-2015 08:40 AM

Tobira Therapeutics, Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-13-2015 08:40 AM. Venue: Encore at the Wynn, 3131 S Las Vegas Blvd, Las Vegas, Nevada, United States.

Tobira Therapeutics, Inc.(NasdaqCM:TBRA) added to Russell 2000 Index

Tobira Therapeutics, Inc. has been added to Russell 2000 Index.

Tobira Therapeutics, Inc.(NasdaqCM:TBRA) added to Russell 3000 Index

Tobira Therapeutics, Inc. has been added to Russell 3000 Index.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TBRA:US $13.84 USD +0.70

TBRA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TBRA.
View Industry Companies
 

Industry Analysis

TBRA

Industry Average

Valuation TBRA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TOBIRA THERAPEUTICS INC, please visit www.tobiratherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.